SCPH scPharmaceuticals Inc

scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, chief executive officer, will present at the following investor conferences in June:

Jefferies 2019 Global Healthcare ConferencePresentation: Friday, June 7, 2019 at 8:30 AM EDTLocation: Grand Hyatt, New York, NY

BMO’s 2019 Prescriptions for Success Healthcare ConferencePresentation: Tuesday, June 25, 2019 at 3:20 PM EDTLocation: Mandarin Oriental, New York, NY

About scPharmaceuticals scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, products for the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit scPharmaceuticals.com.

Contacts:Katherine Taudvin, scPharmaceuticals Inc.781-301-6706ktaudvin@scpharma.com

Christopher F. Brinzey, Westwicke an ICR Company339-970-2843chris.brinzey@westwicke.com